StageZero Life Sciences Ltd banner

StageZero Life Sciences Ltd
F:61N1

Watchlist Manager
StageZero Life Sciences Ltd Logo
StageZero Life Sciences Ltd
F:61N1
Watchlist
Price: 0.0175 EUR Market Closed
Market Cap: €3.8m

Wall St Price Targets

61N1 Price Targets Summary
StageZero Life Sciences Ltd

There are no price targets for 61N1.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
StageZero Life Sciences Ltd Competitors:
Price Targets
CALM
Cal-Maine Foods Inc
9% Upside
3363
FOCI Fiber Optic Communications Inc
-1% Downside

Revenue
Forecast

28% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
28% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 2 years is 22%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for StageZero Life Sciences Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for StageZero Life Sciences Ltd

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for StageZero Life Sciences Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for StageZero Life Sciences Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 61N1's stock price target?
Not Available

61N1 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for StageZero Life Sciences Ltd?
Projected CAGR
22%

Over the last 12 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 2 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett